| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear speck | 6.02e-03 | 431 | 6 | 2 | GO:0016607 | |
| Domain | BHLH | 5.74e-04 | 117 | 6 | 2 | PS50888 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 5.12e-03 | 327 | 5 | 2 | M27565 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 8.10e-06 | 196 | 6 | 3 | M8420 | |
| Coexpression | HAN_SATB1_TARGETS_UP | 8.16e-05 | 425 | 6 | 3 | M9639 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN | 2.59e-04 | 110 | 6 | 2 | M8946 | |
| Coexpression | EGFR_UP.V1_UP | 7.85e-04 | 192 | 6 | 2 | M2634 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL | 7.93e-04 | 193 | 6 | 2 | M45706 | |
| Coexpression | GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 8.10e-04 | 195 | 6 | 2 | M8134 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN | 8.35e-04 | 198 | 6 | 2 | M4554 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 8.43e-04 | 199 | 6 | 2 | M6654 | |
| Coexpression | GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN | 8.43e-04 | 199 | 6 | 2 | M3533 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 8.43e-04 | 199 | 6 | 2 | M3052 | |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_DN | 8.52e-04 | 200 | 6 | 2 | M8359 | |
| Coexpression | GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN | 8.52e-04 | 200 | 6 | 2 | M7042 | |
| Coexpression | GSE2826_XID_VS_BTK_KO_BCELL_DN | 8.52e-04 | 200 | 6 | 2 | M4901 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN | 8.52e-04 | 200 | 6 | 2 | M6270 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 8.52e-04 | 200 | 6 | 2 | M8688 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 8.52e-04 | 200 | 6 | 2 | M8484 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_DN | 8.52e-04 | 200 | 6 | 2 | M3424 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.04e-05 | 91 | 6 | 2 | 9c61b9f3e9e4f0c9cb242e313d642c2b75705c88 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.44e-05 | 101 | 6 | 2 | 1d74f6b30d23e942f26fc57665b5c533ff0c089f | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.44e-05 | 101 | 6 | 2 | 578946c048084f48a74d4352743017f04039d5e8 | |
| ToppCell | Thalamus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.44e-05 | 101 | 6 | 2 | 8a3b8abe06a8c5b546ce40c9429401058fe671d7 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.60e-04 | 148 | 6 | 2 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.60e-04 | 148 | 6 | 2 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | PND28|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 149 | 6 | 2 | d3a025440c8ad284a9291c902403e5888d28e90b | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.89e-04 | 161 | 6 | 2 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 6 | 2 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 6 | 2 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.03e-04 | 167 | 6 | 2 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 171 | 6 | 2 | 1176577841bb6cff27ca288e0c89d2e2242efbb3 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 172 | 6 | 2 | 6c7d03393a60dab954054e34ea842cc77412eb19 | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 172 | 6 | 2 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | 6b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | ecee7e012ccd7876fb9df8aa939f8eb05b0c2b13 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | 693fc31bed0f560644e419fa70ef09f863425416 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.23e-04 | 175 | 6 | 2 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-04 | 175 | 6 | 2 | e7b0eda141b638f1aad9938aaa76b1ce80171be9 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 2.23e-04 | 175 | 6 | 2 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-04 | 177 | 6 | 2 | aadf1d10eccfb014cf3d621b1f01dd6d76df63ac | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.31e-04 | 178 | 6 | 2 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 178 | 6 | 2 | 8fab75295780e18ee7b4556d66b641c20de10dd2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 178 | 6 | 2 | 730720598c530d2a413ef2a3354ecc66ebb4698c | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.34e-04 | 179 | 6 | 2 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-04 | 179 | 6 | 2 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 6 | 2 | 03e3067ee313e8c40b702b9bc9981f9859d045a2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 181 | 6 | 2 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 183 | 6 | 2 | ac70a6ec9270b1bfe089702262d4575a6c42afb4 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 184 | 6 | 2 | 8095be57ed189763b5be039f330149a41e5b406a | |
| ToppCell | droplet-Lung-nan-21m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 185 | 6 | 2 | 43b7345a61e31099718c9cecf194b4e9884b904b | |
| ToppCell | droplet-Lung-21m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-04 | 185 | 6 | 2 | 9c907298166e3dd65b1d1e7673a1b8d01b492bd0 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 186 | 6 | 2 | 61de94c9ba90e7b6780694199c059c798b1488ae | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 186 | 6 | 2 | 298ea4c7f61df65537dfef171ca81d4e976d89c5 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 186 | 6 | 2 | 3e16781b9646de971d953da2c49d4210a4c23fe3 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Proliferating_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-04 | 190 | 6 | 2 | 08420f0ecd2c62e102371d16dcb8eda0d510e92a | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-04 | 190 | 6 | 2 | f5a8b44d9948a16e2d5284c78d8f7ed422ac623a | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 191 | 6 | 2 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.66e-04 | 191 | 6 | 2 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.69e-04 | 192 | 6 | 2 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Early_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.69e-04 | 192 | 6 | 2 | 4986ef70a665fdfa1df86f7f8a15117487eae159 | |
| ToppCell | 18-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 2.72e-04 | 193 | 6 | 2 | 5067b0db24f96e26cf3f9437736415f694e7a614 | |
| ToppCell | critical-Epithelial-Secretory-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.77e-04 | 195 | 6 | 2 | 7889818d0f8b8e5c966fbff74b95a28e3fbcc4d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-04 | 195 | 6 | 2 | 0be50d5bd0bef2240f7ace8056ce22a6ca2961b9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.80e-04 | 196 | 6 | 2 | 81278e696d823744267d6315c4d42799c4ea0b2c | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.80e-04 | 196 | 6 | 2 | 5d5f3c3e9052b7cdca442e39e73b16ca27a16657 | |
| ToppCell | kidney_cells-Adult_normal_reference|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 196 | 6 | 2 | 902965bfc5726ca0f1f0a1f6fe3f6d701cc91e6b | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.80e-04 | 196 | 6 | 2 | 85b697db1c925eff8bbef9d74565c82be5a0ddcc | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.80e-04 | 196 | 6 | 2 | e16f0831f1f677b28e4a8014f0aede7e713d4f04 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.80e-04 | 196 | 6 | 2 | 71e88d9ca28168732bd91f2d4f8f53bb4187963a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-04 | 197 | 6 | 2 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.83e-04 | 197 | 6 | 2 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 2.83e-04 | 197 | 6 | 2 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class | 2.83e-04 | 197 | 6 | 2 | 6172a1b98ff840d9174b1ab20ba0c202a7ef87af | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.83e-04 | 197 | 6 | 2 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-04 | 198 | 6 | 2 | 361f3062f73a0add16dd6fbe927698416515879f | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.86e-04 | 198 | 6 | 2 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-04 | 198 | 6 | 2 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 198 | 6 | 2 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.86e-04 | 198 | 6 | 2 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.86e-04 | 198 | 6 | 2 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-04 | 199 | 6 | 2 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-04 | 199 | 6 | 2 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|Control_saline / Treatment groups by lineage, cell group, cell type | 2.89e-04 | 199 | 6 | 2 | 86d4e5dd3bcc6bafa48fd0211dad39a2456b53be | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.91e-04 | 200 | 6 | 2 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 200 | 6 | 2 | 6a76c8e3d937a9c54eb81cab23b8a898f9600de1 | |
| ToppCell | critical-Epithelial-Secretory-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.91e-04 | 200 | 6 | 2 | 407465404c5818bd2cd9d489bfbf29c3a55429d4 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 200 | 6 | 2 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-04 | 200 | 6 | 2 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 200 | 6 | 2 | 047e00f31ca744f82d61cac0e4e66563381f214b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.91e-04 | 200 | 6 | 2 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-04 | 200 | 6 | 2 | be83f442179ba4217d12f0458059586ff3130991 | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.23e-05 | 196 | 6 | 3 | 2953_DN | |
| Drug | CMCT | 2.18e-05 | 28 | 6 | 2 | CID000084998 | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 7.05e-04 | 158 | 6 | 2 | 2338_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 7.14e-04 | 159 | 6 | 2 | 4325_UP | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 7.77e-04 | 166 | 6 | 2 | 2540_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; MCF7; HT_HG-U133A | 7.77e-04 | 166 | 6 | 2 | 3518_UP | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; HL60; HT_HG-U133A | 8.06e-04 | 169 | 6 | 2 | 2407_UP | |
| Drug | sarcolysin | 8.34e-04 | 172 | 6 | 2 | CID000004053 | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 4637_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 3733_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.02e-03 | 190 | 6 | 2 | 1400_UP | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 6 | 2 | 4314_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 6188_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 3870_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 2653_UP | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 4300_DN | |
| Drug | leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA | 1.07e-03 | 195 | 6 | 2 | 1108_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 2727_DN | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 6039_UP | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2440_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2923_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 5771_UP | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 4683_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 3040_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2047_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2262_UP | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2733_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2978_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; PC3; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 4087_UP | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 3029_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2141_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2980_DN | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3299_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 6083_UP | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 5874_UP | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3999_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3824_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 4195_UP | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 6013_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5837_UP | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5645_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 6742_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 6603_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 4079_UP | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 4425_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 2455_DN | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 7381_UP | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 4337_UP | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; HL60; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 1265_DN | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; HL60; HG-U133A | 1.11e-03 | 199 | 6 | 2 | 1753_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 4159_UP | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 5634_UP | |
| Drug | phenylalanine | 1.22e-03 | 208 | 6 | 2 | CID000000994 | |
| Drug | sodium | 1.29e-03 | 944 | 6 | 3 | CID000000923 | |
| Drug | Fe4S4 | 1.74e-03 | 249 | 6 | 2 | CID000439317 | |
| Disease | cancer (implicated_via_orthology) | 1.20e-03 | 268 | 6 | 2 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLIIMCEPIQHPSHM | 221 | Q99814 | |
| MMHLAFLVLLCLPVC | 1 | P09238 | |
| LPILAMLMALCVHCH | 16 | O43561 | |
| MLMALCVHCHRLPGS | 21 | O43561 | |
| SLHSELMCPICLDML | 41 | Q06587 | |
| LLVMGFIACHCMHIL | 91 | Q495M3 | |
| PLCLMLLMGTVHCQI | 131 | Q9UMS5 | |
| ILMHLCLLPVCMAHL | 71 | Q86TA4 |